| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ZEB1_0003600 | Intron-Exon-Intron | chr10:31642669-31644121 | chr10:31353740-31355192 | 211 nt | 0.3886 |
| hsa_ZEB1_0003700 | Intron-Exon-Intron | chr10:31642669-31647262 | chr10:31353740-31358333 | 189 nt | 0.4603 |
| hsa_ZEB1_0004000 | Intron-Exon-Intron | chr10:31642684-31644121 | chr10:31353755-31355192 | 196 nt | 0.3929 |
| hsa_ZEB1_0004100 | Intron-Exon-Intron | chr10:31642684-31647262 | chr10:31353755-31358333 | 339 nt | 0.4366 |
| hsa_ZEB1_0003800 | Intron-Exon-Intron | chr10:31642684-31663893 | chr10:31353755-31374964 | 250 nt | 0.3240 |
| hsa_ZEB1_0004200 | Intron-Exon-Intron | chr10:31642684-31676195 | chr10:31353755-31387266 | 449 nt | 0.4098 |
| hsa_ZEB1_0004300 | Intron-Exon-Intron | chr10:31642684-31676727 | chr10:31353755-31387798 | 150 nt | 0.4067 |
| hsa_ZEB1_0004400 | Intron-Exon-Intron | chr10:31642684-31678624 | chr10:31353755-31389695 | 241 nt | 0.3983 |
| hsa_ZEB1_0003900 | Intron-Exon-Intron | chr10:31642684-31714071 | chr10:31353755-31425142 | 250 nt | 0.3160 |
| hsa_ZEB1_0004500 | Intron-Exon-Intron | chr10:31642732-31644121 | chr10:31353803-31355192 | 151 nt | 0.3841 |
A study in humans identified the circZEB1 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically validated [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in humans demonstrated that circZEB1 was upregulated in left atrial appendages of patients with atrial fibrillation [Tian et al. DOI:10.3390/molecules26041155].